Wyniki wyszukiwania

1

Will Emicizumab be the support for surgeons in acquired haemophilia?

100%

Chudzik R., Rybojad P.

World Scientific News

|

2019

|

tom 129

2

Fenotypowa charakterystyka gronkowcow koagulazo-ujemnych kolonizujacych dreny po zabiegach torakochirurgicznych u pacjentow z rakiem pluca

71%

Korona-Glowniak I., Los R., Malm A., Rybojad P., Furmanik F.

Medycyna Doświadczalna i Mikrobiologia

|

2003

|

tom 55

|

nr 2

109-115

Scharakteryzowano 33 szczepy gronkowców koagulazo-ujemnych izolowane z wydzieliny zalegającej w drenach chorych poddanych resekcji anatomicznej miąższu płuca z powodu raka. Najczęściej identyfikowano Staphylococcus epidermidis oraz S. warneri. Większość szczepów wykazywała zdolność do produkcji śluzu oraz właściwości hydrofobowe. Przeważały szczepy oporne na penicylinę i oksacylinę, ale wrażliwe na amoksycylinę z kwasem klawulanowym. Dwa szczepy S. haemolyticus wykazywały metycylinooporność.

3

Anaerobic bacteria colonizing the lower airways in lung cancer patients

71%

Rybojad P., Los R., Sawicki M., Tabarkiewicz J., Malm A.

Folia Histochemica et Cytobiologica

|

2011

|

tom 49

|

nr 2

4

Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik

Air pollution: how many cigarettes does each Pole ‘smoke’ every year and how does it influence health, with special respect to lung cancer?

61%

Chudzik R., Rybojad P., Jarosz-Chudzik K., Sawicki M., Rybojad B., Panasiuk L.

Annals of Agricultural and Environmental Medicine

|

2019

|

tom 26

|

nr 4

5

Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer

61%

Rybojad P., Dluski D., Rybojad B., Kedra M., Sawicki M., Skoczylas P., Tabarkiewicz J.

Annals of Agricultural and Environmental Medicine

|

2013

|

tom 20

|

nr 1

Introduction. Besides the undoubted influence of risk factors on morbidity and survival time, there are also other environmental factors, such as awareness of the prevalence of risk factors and the availability of modern diagnosis and treatment methods. Objective. To evaluate differences in lung cancer 5-year overall survival rates between urban and rural patients hospitalized in the Department of Thoracic Surgery of the Medical University in Lublin, Poland, and possible influence of several risk factors on these rates. Materials and methods. The analysis was based on 125 lung cancer patients who underwent surgical procedures in years 2006-2007 and who agreed to take part in the survey. The study aimed at recognition of the health situation and selected demographic traits of people who had been treated surgically for lung cancer. The differences were evaluated between rural and urban inhabitants in gender, age, lung function, smoking habits, exposure to risk factors at work, family history of cancer, staging of the disease, histological type of cancer, post-surgical treatment, and their possible influence on overall survival. Results. The results showed that the only noted differences between urban and rural population were in tobacco smoking and lung function. Survival rates were very similar and did not differ from the European average. Conclusions. The assumption that Polish rural patients are presenting with later cancer stages at the time of diagnosis, and have worse chances for survival, has become invalid in modern times.

6

Reasons for delay in diagnosis and treatment of lung cancer among patients in Lublin Voivodeship who were consulted in Thoracic Surgery Department

61%

Sawicki M., Szczyrek M., Krawczyk P., Rybojad P., Jablonka A., Milanowski J.

Annals of Agricultural and Environmental Medicine

|

2013

|

tom 20

|

nr 1

Introduction: Despite the progress which has been made in the diagnosis and treatment of lung cancer, it is still one of the main causes of death in both men and women. The introduction of new therapeutic modalities did not improve the 5-year survival results of lung cancer patients. The Lublin Voivodeship is a sparsely-inhabited area with little urbanization and a population of about 2.2 million people. Only 46.8% of its citizens live in the towns, while the national average is 61.9%. Objectives: The aim of the study was to compare the differences in the periods of time and reasons for delay in diagnosis and initiation of treatment of lung cancer among patients who are inhabitants of the rural and urban regions of Lublin Voivodeship, and who were consulted in Thoracic Surgery Department. Materials and methods: 300 lung cancer patients who were consulted in the Thoracic Surgery Outpatient Clinic or who were hospitalized in the Department of Thoracic Surgery in the period between 2 January 2010 – 7 January 2011 were included in the study. Delays were calculated for two periods of time: 1) time from the first signs of the disease to the first medical examination; 2) the time from the first visit to a doctor to the start of treatment, or disqualification from the causative treatment. The time of the first delay for the urban and rural populations was similar and ranged from 2-37 weeks and 2-23 weeks, respectively. Lack of time and disregard of signs of disease were the most commonly reasons given for the first delay among rural residents. The urban population indicated fear and lack of time as the main reasons of delay. Assessment of the second reason for delay was possible thanks to a specially designed research protocol which gathered the main reasons of delay in several subgroups that enabled their statistical evaluation. The length of second period was similar for both populations. Results: There were no significant differences in the length of the time of delay between the two assessed groups. In both groups, delays dependent on poor healthcare access were similar. Among rural inhabitants, the most often reasons of delay were waiting for hospital admission and re-bronchoscopy. In the urban population, the most common reasons for delay were waiting for hospitalization and CT procedure. Conclusions: The results of the presented research allowed the following conclusions to be drawn: between the two assessed groups there were no differences in the length of the time of delay; 2) delays in diagnosis and treatment were too long for the patients and could affect the severity of the disease and final prognosis; 3) there is a need for intensification of information campaigns on lung cancer in order to reduce the delays dependent on patients, and to improve the cooperation of family doctors, pulmonologists, thoracic surgeons and oncologists.

7

Impact of preoperative chemotherapy and-or antimicrobial prophylaxis on dynamics of nasopharyngeal microflora in patients with lung cancer during short-term hospitalization

61%

Malm A., Korona-Glowniak I., Kasprzycka A., Rybojad P., Gorniewski G., Furmanik F.

Bulletin of the Veterinary Institute in Puławy. Supplement

|

2002

8

EDTA as a potential agent preventing formation of Staphylococcus epidermidis biofilm on polichloride vinyl biomaterials

61%

Juda M., Paprota K., Jaloza D., Malm A., Rybojad P., Gozdziuk K.

Annals of Agricultural and Environmental Medicine

|

2008

|

tom 15

|

nr 2

Ograniczanie wyników

Will Emicizumab be the support for surgeons in acquired haemophilia?

Fenotypowa charakterystyka gronkowcow koagulazo-ujemnych kolonizujacych dreny po zabiegach torakochirurgicznych u pacjentow z rakiem pluca

Anaerobic bacteria colonizing the lower airways in lung cancer patients

Air pollution: how many cigarettes does each Pole ‘smoke’ every year and how does it influence health, with special respect to lung cancer?

Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer

Reasons for delay in diagnosis and treatment of lung cancer among patients in Lublin Voivodeship who were consulted in Thoracic Surgery Department

Impact of preoperative chemotherapy and-or antimicrobial prophylaxis on dynamics of nasopharyngeal microflora in patients with lung cancer during short-term hospitalization

EDTA as a potential agent preventing formation of Staphylococcus epidermidis biofilm on polichloride vinyl biomaterials